Drug details

Doxycycline Hyclate (doxycycline hyclate delayed-release tablets)

type of

Doxycycline Hyclate Delayed-Release Tablets is a tetracycline-class antibiotic indicated for rickettsial infections, sexually transmitted infections, respiratory tract infections, specific bacterial infections, ophthalmic infections, anthrax (including inhalational anthrax, post-exposure), alternative treatment for selected infections when penicillin is contraindicated, adjunctive therapy in acute intestinal amebiasis and severe acne, and for prophylaxis of malaria. This medication is available in generic form.

The drug is often used to treat Malaria .

This drug may have the following side effects:

• nausea
• rash
• weight loss
• vomiting
• diarrhea
• skin sensitivity to sunlight
• hives
• anemia, and
• vaginal yeast infection

The following drugs are related to Doxycycline Hyclate, either as a replacement or used together:

• Acticlate (doxycycline hyclate tablets, usp)
• Anthrasil (anthrax immune globulin intravenous (human), sterile solution for infusion)
• Declomycin (demeclocycline hcl)
• Monodox (doxycycline)
• Okebo (doxycycline monohydrate capsules)
• Flagyl (metronidazole)
• Flagyl ER (metronidazole extended release tablets)
• Flagyl Injection (metronidazole injection)
• Halfan (halofantrine hydrochloride tablets)
• Krintafel (tafenoquine tablets)
• Minocin (minocycline hydrochloride oral suspension)
• Minocin Capsules (minocycline)
• Minocin Injection (minocycline inj)
• Ximino (minocycline hydrochloride)
• Moxidectin (moxidectin tablets)
• Urobiotic (oxytetracycline, sulfamethizole and phenazopyridine)
• Tygacil (tigecycline)